Achieving Diversity in Pharmaceutical Clinical Trials

Research has shown that differences in biology and genetics may influence the efficacy of pharmaceutical treatments. If a potential compound’s performance is evaluated in a homogenous trial population, such results may not apply to a heterogeneous patient population.